
Rhythm Pharmaceuticals develops therapies for rare MC4R pathway diseases through research, diagnosis, and treatment advancements.
Scientific Affairs Manager for Rare Genetic Disease of Obesity, responsible for building peer-to-peer relationships with external experts and stakeholders, providing clinical, scientific, and medical education, and supporting research initiatives and advisory boards.